Nasal spray vaccine aims to stop COVID at the nose
NCT ID NCT05736835
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 36 times
Summary
This study tests a new COVID-19 vaccine given as a single nasal spray. It aims to see if it is safe and triggers a strong immune response. About 227 healthy adults aged 18 to 80 are taking part. The vaccine is designed to fight the virus right where it enters the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
University of Rochester
Rochester, New York, 14642, United States
-
Velocity Clinical Research
San Diego, California, 91942, United States
-
Velocity Clinical Research
Boise, Idaho, 83642, United States
-
Velocity Clinical Research
Sioux City, Iowa, 51106, United States
-
Velocity Clinical Research
Rockville, Maryland, 20854, United States
-
Velocity Clinical Research
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research
Vestal, New York, 13850, United States
-
Velocity Clinical Research
Providence, Rhode Island, 02818, United States
-
Velocity Clinical Research
Cedar Park, Texas, 78759, United States
Conditions
Explore the condition pages connected to this study.